文献速递肝胆胰外科围术期管理与 ERAS

体重指数对慢性胰腺炎远端胰腺切除术结局的影响

Distal pancreatectomy for chronic pancreatitis: The influence of body mass index.
PubMed 文献 · Surgery · 2025-09-23

本研究分析2007至2022年186例因慢性胰腺炎行远端胰腺切除术的患者,采用NSQIP协议采集围术期数据。

要点

  • 慢性胰腺炎行远端胰腺切除术在部分患者中安全可行,无术后死亡。
  • BMI升高是临床相关术后胰瘘的独立预测因素。
  • BMI>25.4 kg/m²者临床相关胰瘘风险较高,应考虑瘘 mitigation 策略。

核心结论

  • 慢性胰腺炎患者行远端胰腺切除术在选定患者中可安全实施。
  • 体重指数升高可预测临床相关术后胰瘘,提示应在此类患者中采用瘘 mitigation 策略。

研究设计与样本

  • 回顾性队列研究,纳入2007至2022年因慢性胰腺炎行远端胰腺切除术的186例患者。
  • 通过机构NSQIP协议采集手术数据、患者合并症及围术期结局。
  • 采用描述性统计、单变量及多变量分析评估与结局相关的因素。

主要发现

  • 186例患者中女性占41%,平均年龄50.1(±12.7)岁。
  • 开放手术149例(80%),使用手术引流占85%。
  • 中位住院时间6(四分位距4)天,30天再入院率12%,并发症发生率41%。
  • 术后胰瘘60例(43%),其中生化漏34例(18%)、B级25例(13%)、C级1例,无术后死亡。

关键数值与推荐

  • BMI<25.5 kg/m²者临床相关术后胰瘘发生率为6.4%。

临床怎么用

  • 对慢性胰腺炎行远端胰腺切除术的患者,应评估BMI以识别临床相关胰瘘高风险者。
  • BMI>25.4 kg/m²的患者应考虑采用瘘 mitigation 策略。
  • 器官间隙感染与临床相关胰瘘相关,围术期需关注感染防控。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A relatively small number of patients with chronic pancreatitis have disease localized to the pancreatic tail. These patients benefit from distal pancreatectomy; however, disease-related inflammation and vascular involvement complicate surgery. Few large studies have analyzed distal pancreatectomy outcomes in chronic pancreatitis. We hypothesized that patient and disease-related features may predict outcomes of distal pancreatectomy for chronic pancreatitis. METHODS: Patients with chronic pancreatitis undergoing distal pancreatectomy from 2007 to 2022 were analyzed. Operative data, patient comorbidities, and perioperative outcomes were captured via institutional National Surgical Quality Improvement Program protocol. Descriptive statistics, univariate, and multivariable analyses were performed to evaluate factors associated with outcome, including clinically relevant postoperative pancreatic fistula. RESULTS: Among 186 patients analyzed, 41% were female with mean age of 50.1 (±12.7) years. Most operations (149, 80%) were performed open, and surgical drains were used in 85%. Median length of stay was 6 (interquartile range, 4) days. The 30-day readmission rate was 12%. Morbidity occurred in 41%. Postoperative pancreatic fistula was seen in 60 (43%); 34 (18%) had biochemical leaks, 25 (13%) had grade B, and 1 patient had grade C postoperative pancreatic fistula. No postoperative mortality occurred. On multivariable analysis, organ space infection (P = .002) and increased body mass index (body mass index, P = .018) were significantly associated with clinically relevant postoperative pancreatic fistula. Patients with body mass index <25.5 kg/m2 had clinically relevant postoperative pancreatic fistula of 6.4%, whereas those with body mass index >25.4 had clinically relevant postoperative pancreatic fistula of 19.4% (P = .047). CONCLUSION: Distal pancreatectomy may be performed safely in select patients with chronic pancreatitis. Increased body mass index predicts clinically relevant postoperative pancreatic fistula, highlighting patients in whom fistula mitigation strategy should be used.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Lewellen KA, Kim RC, Maatman TK, et al. Distal pancreatectomy for chronic pancreatitis: The influence of body mass index. Surgery. 2025. PMID: 40992296. doi:10.1016/j.surg.2025.109722

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。